author-photo

Harry L.A. Janssen

Erasmus University Rotterdam
University Health Network
University of Toronto

578

Papers

26499

Citations

Citation Trend

Filter By

Papers (578) Sort By

Journal Conference Others

An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.

2021 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study.

2021 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (2)
Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV

2021
Show All
- Source
- Cite
- Save
Citations (0)
Peginterferon-Lambda for the Treatment of COVID-19 in Outpatients

2021
Show All
- Source
- Cite
- Save
Citations (1)
IDDF2021-ABS-0079 Switching from tenofovir disoproxil fumarate (TDF) and/or other oral antivirals (OAVS) to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with hepatic impairment: final 2-year efficacy and safety results from a phase 2

2021 Gut
Show All
- Source
- Cite
- Save
Citations (0)
Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort.

2021 Alimentary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (2)
Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update.

2021 Clinical Gastroenterology and Hepatology
Show All
- Source
- Cite
- Save
Citations (1)
Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver.

2021 JCI insight
Show All
- Source
- Cite
- Save
Citations (2)
Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus-infected patients with low ALT levels in the absence of significant fibrosis-authors' reply.

2021 Alimentary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (1)
Controversies in Treating Chronic Hepatitis B Virus Infection: Discordant Serologic Results.

2021 Clinics in Liver Disease
Show All
- Source
- Cite
- Save
Citations (0)